Cavanaugh Group, Inc.’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$77.7K Buy
+220
New +$58K 0.03% 64

Other funds holding CRL

Cavanaugh Group, Inc.'s CRL Position: Q3 2026 in Review

Cavanaugh Group, Inc. opened a new position in Charles River Laboratories (CRL) in Q3 2026: 220 shares worth $77.7K. The stake represents 0.03% of the portfolio and ranks #64 among its holdings.

642 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Cavanaugh Group, Inc. held 220 shares of Charles River Laboratories worth $77.7K as of Q3 2026.
  • Charles River Laboratories was a new Cavanaugh Group, Inc. position in Q3 2026.
  • Charles River Laboratories made up 0.03% of Cavanaugh Group, Inc.'s portfolio in Q3 2026, its #64 holding.
  • 642 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Cavanaugh Group, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.